Clinical trial

MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis

NCT06592352

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-08-27

PhasePHASE2

Study timeline

Study start (actual)2024-08-27Date precision: day

Registry last updated2025-08-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Cognitive Impairmentunresolved

Interventions

Modafinil Generis 100 mgDRUG

Sponsors & collaborators

Clinical Academic Center (2CA-Braga)lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06592352 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.